Selected research
Industry Research
Drug Release Platform Industry Research Report 2026
Market perspective
The global Drug Release Platform market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Drug Release Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Drug Release Platform market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Drug Release Platform market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Drug Release Platform include Evonik, Camurus, Pacira BioSciences, Starpharma, ProLynx, Liquidia, MedinCell, Intarcia and Corium, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Drug Release Platform market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Drug Release Platform.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug Release Platform Market by Company
Evonik
Camurus
Pacira BioSciences
Starpharma
ProLynx
Liquidia
MedinCell
Intarcia
Corium
Enable Injections
Alkermes
Depomed
NanoCarrier
Lyndra
Hisun Pharmaceutical
Livzon Pharmaceutical Group
Hengrui Pharmaceuticals
HEC ChangJiang Pharmaceutical
Luye Pharma
Lanna Bio
Drug Release Platform Segment by Type
Oral Sustained-Release Platform
Implantable Sustained-Release Platform
Local Sustained-Release Platform
Drug Release Platform Segment by Application
Pharmaceutical Companies
Hospitals
Others
Drug Release Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Release Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Release Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Release Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug Release Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Sustained-Release Platform
- Implantable Sustained-Release Platform
- Local Sustained-Release Platform
Applications
- Pharmaceutical Companies
- Hospitals
- Others
Companies covered
- Evonik
- Camurus
- Pacira BioSciences
- Starpharma
- ProLynx
- Liquidia
- MedinCell
- Intarcia
- Corium
- Enable Injections
- Alkermes
- Depomed
- NanoCarrier
- Lyndra
- Hisun Pharmaceutical
- Livzon Pharmaceutical Group
- Hengrui Pharmaceuticals
- HEC ChangJiang Pharmaceutical
- Luye Pharma
- Lanna Bio
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Drug Release Platform by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Oral Sustained-Release Platform
- 2.2.3 Implantable Sustained-Release Platform
- 2.2.4 Local Sustained-Release Platform
- 2.3 Drug Release Platform by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Companies
- 2.3.3 Hospitals
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Drug Release Platform Breakdown Data by Type
- 3.1 Global Drug Release Platform Historic Market Size by Type (2021-2026)
- 3.2 Global Drug Release Platform Forecasted Market Size by Type (2027-2032)
4 Drug Release Platform Breakdown Data by Application
- 4.1 Global Drug Release Platform Historic Market Size by Application (2021-2026)
- 4.2 Global Drug Release Platform Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Drug Release Platform Market Perspective (2021-2032)
- 5.2 Global Drug Release Platform Growth Trends by Region
- 5.2.1 Global Drug Release Platform Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Drug Release Platform Historic Market Size by Region (2021-2026)
- 5.2.3 Drug Release Platform Forecasted Market Size by Region (2027-2032)
- 5.3 Drug Release Platform Market Dynamics
- 5.3.1 Drug Release Platform Industry Trends
- 5.3.2 Drug Release Platform Market Drivers
- 5.3.3 Drug Release Platform Market Challenges
- 5.3.4 Drug Release Platform Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Drug Release Platform Players by Revenue
- 6.1.1 Global Top Drug Release Platform Players by Revenue (2021-2026)
- 6.1.2 Global Drug Release Platform Revenue Market Share by Players (2021-2026)
- 6.2 Global Drug Release Platform Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Drug Release Platform Head Office and Area Served
- 6.4 Global Drug Release Platform Players, Product Type & Application
- 6.5 Global Drug Release Platform Manufacturers Established Date
- 6.6 Global Drug Release Platform Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Drug Release Platform Market Size (2021-2032)
- 7.2 North America Drug Release Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Drug Release Platform Market Size by Country (2021-2026)
- 7.4 North America Drug Release Platform Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Drug Release Platform Market Size (2021-2032)
- 8.2 Europe Drug Release Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Drug Release Platform Market Size by Country (2021-2026)
- 8.4 Europe Drug Release Platform Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Drug Release Platform Market Size (2021-2032)
- 9.2 Asia-Pacific Drug Release Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Drug Release Platform Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Drug Release Platform Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Drug Release Platform Market Size (2021-2032)
- 10.2 South America Drug Release Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Drug Release Platform Market Size by Country (2021-2026)
- 10.4 South America Drug Release Platform Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Drug Release Platform Market Size (2021-2032)
- 11.2 Middle East & Africa Drug Release Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Drug Release Platform Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Drug Release Platform Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Evonik
- 12.1.1 Evonik Company Information
- 12.1.2 Evonik Business Overview
- 12.1.3 Evonik Revenue in Drug Release Platform Business (2021-2026)
- 12.1.4 Evonik Drug Release Platform Product Portfolio
- 12.1.5 Evonik Recent Developments
- 12.2 Camurus
- 12.2.1 Camurus Company Information
- 12.2.2 Camurus Business Overview
- 12.2.3 Camurus Revenue in Drug Release Platform Business (2021-2026)
- 12.2.4 Camurus Drug Release Platform Product Portfolio
- 12.2.5 Camurus Recent Developments
- 12.3 Pacira BioSciences
- 12.3.1 Pacira BioSciences Company Information
- 12.3.2 Pacira BioSciences Business Overview
- 12.3.3 Pacira BioSciences Revenue in Drug Release Platform Business (2021-2026)
- 12.3.4 Pacira BioSciences Drug Release Platform Product Portfolio
- 12.3.5 Pacira BioSciences Recent Developments
- 12.4 Starpharma
- 12.4.1 Starpharma Company Information
- 12.4.2 Starpharma Business Overview
- 12.4.3 Starpharma Revenue in Drug Release Platform Business (2021-2026)
- 12.4.4 Starpharma Drug Release Platform Product Portfolio
- 12.4.5 Starpharma Recent Developments
- 12.5 ProLynx
- 12.5.1 ProLynx Company Information
- 12.5.2 ProLynx Business Overview
- 12.5.3 ProLynx Revenue in Drug Release Platform Business (2021-2026)
- 12.5.4 ProLynx Drug Release Platform Product Portfolio
- 12.5.5 ProLynx Recent Developments
- 12.6 Liquidia
- 12.6.1 Liquidia Company Information
- 12.6.2 Liquidia Business Overview
- 12.6.3 Liquidia Revenue in Drug Release Platform Business (2021-2026)
- 12.6.4 Liquidia Drug Release Platform Product Portfolio
- 12.6.5 Liquidia Recent Developments
- 12.7 MedinCell
- 12.7.1 MedinCell Company Information
- 12.7.2 MedinCell Business Overview
- 12.7.3 MedinCell Revenue in Drug Release Platform Business (2021-2026)
- 12.7.4 MedinCell Drug Release Platform Product Portfolio
- 12.7.5 MedinCell Recent Developments
- 12.8 Intarcia
- 12.8.1 Intarcia Company Information
- 12.8.2 Intarcia Business Overview
- 12.8.3 Intarcia Revenue in Drug Release Platform Business (2021-2026)
- 12.8.4 Intarcia Drug Release Platform Product Portfolio
- 12.8.5 Intarcia Recent Developments
- 12.9 Corium
- 12.9.1 Corium Company Information
- 12.9.2 Corium Business Overview
- 12.9.3 Corium Revenue in Drug Release Platform Business (2021-2026)
- 12.9.4 Corium Drug Release Platform Product Portfolio
- 12.9.5 Corium Recent Developments
- 12.10 Enable Injections
- 12.10.1 Enable Injections Company Information
- 12.10.2 Enable Injections Business Overview
- 12.10.3 Enable Injections Revenue in Drug Release Platform Business (2021-2026)
- 12.10.4 Enable Injections Drug Release Platform Product Portfolio
- 12.10.5 Enable Injections Recent Developments
- 12.11 Alkermes
- 12.11.1 Alkermes Company Information
- 12.11.2 Alkermes Business Overview
- 12.11.3 Alkermes Revenue in Drug Release Platform Business (2021-2026)
- 12.11.4 Alkermes Drug Release Platform Product Portfolio
- 12.11.5 Alkermes Recent Developments
- 12.12 Depomed
- 12.12.1 Depomed Company Information
- 12.12.2 Depomed Business Overview
- 12.12.3 Depomed Revenue in Drug Release Platform Business (2021-2026)
- 12.12.4 Depomed Drug Release Platform Product Portfolio
- 12.12.5 Depomed Recent Developments
- 12.13 NanoCarrier
- 12.13.1 NanoCarrier Company Information
- 12.13.2 NanoCarrier Business Overview
- 12.13.3 NanoCarrier Revenue in Drug Release Platform Business (2021-2026)
- 12.13.4 NanoCarrier Drug Release Platform Product Portfolio
- 12.13.5 NanoCarrier Recent Developments
- 12.14 Lyndra
- 12.14.1 Lyndra Company Information
- 12.14.2 Lyndra Business Overview
- 12.14.3 Lyndra Revenue in Drug Release Platform Business (2021-2026)
- 12.14.4 Lyndra Drug Release Platform Product Portfolio
- 12.14.5 Lyndra Recent Developments
- 12.15 Hisun Pharmaceutical
- 12.15.1 Hisun Pharmaceutical Company Information
- 12.15.2 Hisun Pharmaceutical Business Overview
- 12.15.3 Hisun Pharmaceutical Revenue in Drug Release Platform Business (2021-2026)
- 12.15.4 Hisun Pharmaceutical Drug Release Platform Product Portfolio
- 12.15.5 Hisun Pharmaceutical Recent Developments
- 12.16 Livzon Pharmaceutical Group
- 12.16.1 Livzon Pharmaceutical Group Company Information
- 12.16.2 Livzon Pharmaceutical Group Business Overview
- 12.16.3 Livzon Pharmaceutical Group Revenue in Drug Release Platform Business (2021-2026)
- 12.16.4 Livzon Pharmaceutical Group Drug Release Platform Product Portfolio
- 12.16.5 Livzon Pharmaceutical Group Recent Developments
- 12.17 Hengrui Pharmaceuticals
- 12.17.1 Hengrui Pharmaceuticals Company Information
- 12.17.2 Hengrui Pharmaceuticals Business Overview
- 12.17.3 Hengrui Pharmaceuticals Revenue in Drug Release Platform Business (2021-2026)
- 12.17.4 Hengrui Pharmaceuticals Drug Release Platform Product Portfolio
- 12.17.5 Hengrui Pharmaceuticals Recent Developments
- 12.18 HEC ChangJiang Pharmaceutical
- 12.18.1 HEC ChangJiang Pharmaceutical Company Information
- 12.18.2 HEC ChangJiang Pharmaceutical Business Overview
- 12.18.3 HEC ChangJiang Pharmaceutical Revenue in Drug Release Platform Business (2021-2026)
- 12.18.4 HEC ChangJiang Pharmaceutical Drug Release Platform Product Portfolio
- 12.18.5 HEC ChangJiang Pharmaceutical Recent Developments
- 12.19 Luye Pharma
- 12.19.1 Luye Pharma Company Information
- 12.19.2 Luye Pharma Business Overview
- 12.19.3 Luye Pharma Revenue in Drug Release Platform Business (2021-2026)
- 12.19.4 Luye Pharma Drug Release Platform Product Portfolio
- 12.19.5 Luye Pharma Recent Developments
- 12.20 Lanna Bio
- 12.20.1 Lanna Bio Company Information
- 12.20.2 Lanna Bio Business Overview
- 12.20.3 Lanna Bio Revenue in Drug Release Platform Business (2021-2026)
- 12.20.4 Lanna Bio Drug Release Platform Product Portfolio
- 12.20.5 Lanna Bio Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst